An efficient rapid system for profiling the cellular activities of molecular libraries

被引:149
作者
Melnick, JS
Janes, J
Kim, S
Chang, JY
Sipes, DG
Gunderson, D
Jarnes, L
Matzen, JT
Garcia, ME
Hood, TL
Beigi, R
Xia, G
Harig, RA
Asatryan, H
Yan, SF
Zhou, YY
Gu, XJ
Saadat, A
Zhou, V
King, FJ
Shaw, CM
Su, AI
Downs, R
Gray, NS
Schultz, PG
Warmuth, M
Caldwell, JS
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
[2] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
关键词
drug discovery; high-throughput screening; tyrosine kinase;
D O I
10.1073/pnas.0511292103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Rapid quantitative methods for characterizing small molecules, peptides, proteins, or RNAs in a broad array of cellular assays would allow one to discover new biological activities associated with these molecules and also provide a more comprehensive profile of drug candidates early in the drug development process. Here we describe a robotic system, termed the automated compound profiler, capable of both propagating a large number of cell lines in parallel and assaying large collections of molecules simultaneously against a matrix of cellular assays in a highly reproducible manner. To illustrate its utility, we have characterized a set of 1,400 kinase inhibitors in a panel of 35 activated tyrosine-kinase-dependent cellular assays in dose-response format in a single experiment. Analysis of the resulting multidimensional dataset revealed subclusters of both inhibitors and kinases with closely correlated activities. The approach also identified activities for the p38 inhibitor BIRB796 and the dual src/abl inhibitor BMS-354825 and exposed the expected side activities for Glivec/STI571, including cellular inhibition of c-kit and platelet-derived growth factor receptor. This methodology provides a powerful tool for unraveling the cellular biology and molecular pharmacology of both naturally occurring and synthetic chemical diversity.
引用
收藏
页码:3153 / 3158
页数:6
相关论文
共 35 条
[1]   Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity [J].
Bai, RY ;
Dieter, P ;
Peschel, C ;
Morris, SW ;
Duyster, J .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :6951-6961
[2]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[3]  
Boolell M, 1996, Int J Impot Res, V8, P47
[4]   Eph receptor tyrosine kinases in tumor and tumor microenvironment [J].
Brantley-Sieders, D ;
Schmidt, S ;
Parker, M ;
Chen, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (27) :3431-3442
[5]   Eph receptor tyrosine kinases in angiogenesis: From development to disease [J].
Brantley-Sieders D.M. ;
Chen J. .
Angiogenesis, 2004, 7 (1) :17-28
[6]   Systems biology in drug discovery [J].
Butcher, EC ;
Berg, EL ;
Kunkel, EJ .
NATURE BIOTECHNOLOGY, 2004, 22 (10) :1253-1259
[7]  
Christensen JG, 2003, CANCER RES, V63, P7345
[8]   TRANSFORMATION OF AN INTERLEUKIN-3-DEPENDENT HEMATOPOIETIC-CELL LINE BY THE CHRONIC MYELOGENOUS LEUKEMIA-SPECIFIC P210BER/ABL PROTEIN [J].
DALEY, GQ ;
BALTIMORE, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9312-9316
[9]   A concise and traceless linker strategy toward combinatorial libraries of 2,6,9-substituted purines [J].
Ding, S ;
Gray, NS ;
Ding, Q ;
Schultz, PG .
JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (24) :8273-8276
[10]   Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) [J].
Eguchi, M ;
Eguchi-Ishimae, M ;
Tojo, A ;
Morishita, K ;
Suzuki, K ;
Sato, Y ;
Kudoh, S ;
Tanaka, K ;
Setoyama, M ;
Nagamura, F ;
Asano, S ;
Kamada, N .
BLOOD, 1999, 93 (04) :1355-1363